Oncology & Cancer

Early, encouraging data for glioblastoma treatment reported at ASCO

All of the newly diagnosed glioblastoma multiforme patients enrolled in a Phase 1 clinical trial at the University of Alabama at Birmingham have exceeded both their median and expected progression-free survivals. Two patients, ...


A-fib detected in nearly three in 10 cryptogenic stroke patients

Almost one in three patients surviving a stroke of unknown cause have atrial fibrillation (AF) detectable using continuous cardiac monitoring, according to a study presented at the annual meeting of the European Heart Rhythm ...


AI-based scheduling may help reduce physician burnout

(HealthDay)—Use of artificial intelligence (AI)-based scheduling software to create more flexible work schedules may improve physician engagement and help reduce burnout, according to a study presented at the American Society ...


Skyrizi approved for psoriatic arthritis

(HealthDay)—The U.S. Food and Drug Administration has expanded the approval of Skyrizi (risankizumab-rzaa) to treatment of adults with active psoriatic arthritis, the manufacturer announced Friday.

Diseases, Conditions, Syndromes

US stores put limits on at-home COVID test buys due to high demand

The resumption of holiday travel coupled with the rapidly spreading Omicron variant left Americans scrambling Wednesday to find at-home COVID tests, leading multiple major distributors to limit the number of kits per customer.

page 1 from 9